Avgemsi

Active Ingredient(s): Gemcitabine
FDA Approved: * June 27, 2025
Pharm Company: * AVYXA HOLDINGS
Category: Cancer

Gemcitabine, with brand names including Gemzar,[1] is a chemotherapy medication.[2] It treats cancers including testicular cancer,[3] breast cancer, ovarian cancer, non-small cell lung cancer, pancreatic cancer, and bladder cancer.[2][4] It is administered by intravenous infusion.[2] It acts against neoplastic growth, and it inhibits the replication of Orthohepevirus A, the causative agent of Hepat... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Avgemsi 38 mg/ml Intravenous Injection, Solution
NDC: 83831-123
Labeler:
Avyxa Pharma, LLC
Avgemsi 38 mg/ml Intravenous Injection, Solution
NDC: 83831-124
Labeler:
Avyxa Pharma, LLC

Related Brands

Drugs with the same active ingredients